These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 30475382)

  • 1. STIM promotes the epithelial-mesenchymal transition of podocytes through regulation of FcγRII activity in diabetic nephropathy.
    Jin J; Ye M; Hu K; Gong J; He Q
    Histol Histopathol; 2019 Jun; 34(6):671-682. PubMed ID: 30475382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tripterygium glycoside suppresses epithelial‑to‑mesenchymal transition of diabetic kidney disease podocytes by targeting autophagy through the mTOR/Twist1 pathway.
    Tao M; Zheng D; Liang X; Wu D; Hu K; Jin J; He Q
    Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34165172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of CTGF Antibody Against Diabetic Nephropathy in Mice Via Reducing Glomerular β-Catenin Expression and Podocyte Epithelial-Mesenchymal Transition.
    Dai HY; Ma LN; Cao Y; Chen XL; Shi H; Fan YP; Yang B
    J Cell Biochem; 2017 Nov; 118(11):3706-3712. PubMed ID: 28370212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tripterygium glycoside protects diabetic kidney disease mouse serum-induced podocyte injury by upregulating autophagy and downregulating β-arrestin-1.
    Zhan H; Jin J; Liang S; Zhao L; Gong J; He Q
    Histol Histopathol; 2019 Aug; 34(8):943-952. PubMed ID: 30839094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory stress exacerbates lipid accumulation and podocyte injuries in diabetic nephropathy.
    Zhang Y; Ma KL; Liu J; Wu Y; Hu ZB; Liu L; Lu J; Zhang XL; Liu BC
    Acta Diabetol; 2015 Dec; 52(6):1045-56. PubMed ID: 25896009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emodin ameliorates high glucose induced-podocyte epithelial-mesenchymal transition in-vitro and in-vivo.
    Chen T; Zheng LY; Xiao W; Gui D; Wang X; Wang N
    Cell Physiol Biochem; 2015; 35(4):1425-36. PubMed ID: 25791065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PFKP Activation Ameliorates Foot Process Fusion in Podocytes in Diabetic Kidney Disease.
    Zhang Z; Liang W; Luo Q; Hu H; Yang K; Hu J; Chen Z; Zhu J; Feng J; Zhu Z; Chi Q; Ding G
    Front Endocrinol (Lausanne); 2021; 12():797025. PubMed ID: 35095764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of high mobility group box 1 (HMGB1) attenuates podocyte apoptosis and epithelial-mesenchymal transition by regulating autophagy flux.
    Jin J; Gong J; Zhao L; Zhang H; He Q; Jiang X
    J Diabetes; 2019 Oct; 11(10):826-836. PubMed ID: 30864227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy.
    Zhang M; Liu M; Xiong M; Gong J; Tan X
    J Ethnopharmacol; 2012 May; 141(1):111-8. PubMed ID: 22353431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effects and mechanism of Tripterygium wilfordii Hook F combination with irbesartan on urinary podocyte excretion in diabetic nephropathy patients].
    Ma RX; Zhao N; Zhang W
    Zhonghua Nei Ke Za Zhi; 2013 Jun; 52(6):469-73. PubMed ID: 24059992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical role of serum response factor in podocyte epithelial-mesenchymal transition of diabetic nephropathy.
    Zhao L; Wang X; Sun L; Nie H; Liu X; Chen Z; Guan G
    Diab Vasc Dis Res; 2016 Jan; 13(1):81-92. PubMed ID: 26408645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Jixuepaidu Tang-1 inhibits epithelial-mesenchymal transition and alleviates renal damage in DN mice through suppressing long non-coding RNA LOC498759.
    Jin J; Zhang Z; Chen J; Liu Y; Chen Q; Wang Q
    Cell Cycle; 2019 Nov; 18(22):3125-3136. PubMed ID: 31564202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-124a enhances therapeutic effects of bone marrow stromal cells transplant on diabetic nephropathy-related epithelial-to-mesenchymal transition and fibrosis.
    Cai X; Wang L; Wang X; Hou F
    J Cell Biochem; 2020 Jan; 121(1):299-312. PubMed ID: 31190436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of berberine on the renal tubular epithelial-to-mesenchymal transition by inhibition of the Notch/snail pathway in diabetic nephropathy model KKAy mice.
    Yang G; Zhao Z; Zhang X; Wu A; Huang Y; Miao Y; Yang M
    Drug Des Devel Ther; 2017; 11():1065-1079. PubMed ID: 28408805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cell-derived exosomes ameliorate diabetic kidney disease through NOD2 signaling pathway.
    Wang Y; Lu D; Lv S; Liu X; Liu G
    Ren Fail; 2024 Dec; 46(2):2381597. PubMed ID: 39039856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deciphering the molecular nexus of BTG2 in periodontitis and diabetic kidney disease.
    Pan B; Teng Y; Wang R; Chen D; Chen H
    BMC Med Genomics; 2024 Jun; 17(1):152. PubMed ID: 38831322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sirt6 ameliorates high glucose-induced podocyte cytoskeleton remodeling via the PI3K/AKT signaling pathway.
    Zhang Z; Huang H; Tao Y; Liu H; Fan Y
    Ren Fail; 2024 Dec; 46(2):2410396. PubMed ID: 39378103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycogen synthase kinase‑3β is required for epithelial‑mesenchymal transition and barrier dysfunction in mouse podocytes under high glucose conditions.
    Guo J; Yang L; Qiao Y; Liu Z
    Mol Med Rep; 2016 Nov; 14(5):4091-4098. PubMed ID: 27748847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RIPK3 causes mitochondrial dysfunction and albuminuria in diabetic podocytopathy through PGAM5-Drp1 signaling.
    Kang JS; Cho NJ; Lee SW; Lee JG; Lee JH; Yi J; Choi MS; Park S; Gil HW; Oh JC; Son SS; Park MJ; Moon JS; Lee D; Kim SY; Yang SH; Kim SS; Lee ES; Chung CH; Park J; Lee EY
    Metabolism; 2024 Oct; 159():155982. PubMed ID: 39089491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects and mechanisms of total flavones of Abelmoschus manihot in improving insulin resistance and podocyte epithelial-mesenchymal transition in diabetic kidney disease based on IRS1/PI3K/Akt pathway].
    Wang Y; Cao DW; Wan YG; Mu GL; Wu W; Fang QJ; Li YJ; Cha SY; Tu Y; Wan ZY
    Zhongguo Zhong Yao Za Zhi; 2023 May; 48(10):2646-2656. PubMed ID: 37282926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.